In vitro transformation by hepatitis B virus DNA

Area of Science:

• Hepatology
• Virology
• Oncology

Background:

• Hepatitis B virus (HBV) is epidemiologically linked to hepatocellular carcinoma (HCC).
• In vitro studies demonstrate transforming activity of HBV DNA and the viral protein X (HBx).
• The role of other HBV genome parts beyond HBx in in vitro transformation is suggested.

Purpose of the Study:

• To investigate the transforming activity of HBV DNA and its components in vitro.
• To explore the role of viral DNA integration and recombination in HCC development.
• To assess the influence of chemical carcinogens in HBV-associated models.

Main Methods:

• In vitro transformation assays using cell lines with HBV DNA and HBx expression vectors.
• Analysis of HBx-transgenic and large surface protein transgenic mouse models.
• Investigation of viral DNA integration and cellular DNA recombination.
• Studies on the effect of chemical carcinogens in HBV-containing cell lines and mouse models.

Main Results:

• HBV DNA and HBx exhibit in vitro transforming activity.
• Transgenic mouse models show HCC development, linked to HBx or large surface protein expression and necroinflammation.
• Recombination between integrated viral DNA and host DNA is implicated in HCC.
• A specific viral integrate demonstrated direct transforming potential.
• Chemical carcinogens enhance oncogenesis in HBV-positive systems.

Conclusions:

• HBV contributes to hepatocellular carcinoma through multiple mechanisms, including viral protein activity and DNA integration.
• Viral DNA recombination with host DNA is a significant factor in HCC pathogenesis.
• HBV-infected cells and animals are more susceptible to chemical carcinogens, highlighting a synergistic effect in liver cancer development.